About
eSight was founded in Canada and is now part of Gentex Corporation (acquired in 2024). The device is clinically supported and prescribed in partnership with low vision optometrists, with peer-reviewed research backing its effectiveness for central vision loss conditions.
What It Does
eSight captures high-definition video from a front-facing camera and projects it onto two OLED screens directly in front of the user's eyes, with real-time controls for zoom, contrast, brightness, and colour filtering. Unlike screen magnification software, eSight enhances real-world vision—faces, menus, whiteboards, television, and outdoor scenes—without requiring a computer. The eSight Go (2024) added increased field of view, improved image stabilisation, and a lighter, more compact frame.
Who It Helps
eSight is used by people with age-related macular degeneration, Stargardt disease, diabetic retinopathy, uveitis, optic nerve hypoplasia, and other conditions causing central vision loss. It can help users with visual acuity as low as 20/800 achieve functional enhanced vision in daily activities.